Filing Details
- Accession Number:
- 0000899243-19-025423
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-10 16:52:38
- Reporting Period:
- 2019-10-08
- Accepted Time:
- 2019-10-10 16:52:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1629137 | Global Blood Therapeutics Inc. | GBT | Air Transportation, Scheduled (4512) | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1053466 | L Deval Patrick | C/O Global Blood Therapeutics, Inc. 171 Oyster Point Blvd., Suite 300 South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-10-08 | 5,357 | $3.40 | 5,357 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-10-08 | 5,357 | $45.05 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-10-08 | 5,357 | $0.00 | 5,357 | $3.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-04-08 | No | 4 | M | Direct |
Footnotes
- 25% of the shares subject to this option vested and became exercisable on April 8, 2016, and the remaining shares subject to this option vested and became exercisable in 12 equal quarterly installments thereafter.